Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Macaulay

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Endocrine-Related Cancer|January 30, 2007
IGF1R signalling and its inhibitionJ Riedemann, V M Macaulay
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
The insulin-like growth factor system as a therapeutic target in colorectal cancerA B Hassan, V M Macaulay
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 8, 2004
Development of molecular agents for IGF receptor targetingA J Salisbury, V M Macaulay
Oncogene|May 23, 2006
Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAsA H Yeh, E A Bohula, V M Macaulay
Postgraduate Medical Journal|April 1, 1985
Atrial myxoma presenting with cerebral haemorrhageV M Macaulay, P J Crawford, R O McKeran
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-cateninM P Playford, D Bicknell, W F Bodmer, et al.
The Journal of Endocrinology|September 1, 1993
Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymesV J Frost, V M Macaulay, J A Wass, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapyV M Macaulay, R H Begent, M E Phillips, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
[D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P inhibits the growth of human small cell lung cancer xenografts in vivoM J Everard, V M Macaulay, J L Millar, et al.
British Journal of Cancer|March 1, 1992
In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growthM J Everard, V M Macaulay, J L Miller, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Endocrine-Related Cancer|January 30, 2007
IGF1R signalling and its inhibitionJ Riedemann, V M Macaulay
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
The insulin-like growth factor system as a therapeutic target in colorectal cancerA B Hassan, V M Macaulay
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 8, 2004
Development of molecular agents for IGF receptor targetingA J Salisbury, V M Macaulay
Oncogene|May 23, 2006
Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAsA H Yeh, E A Bohula, V M Macaulay
Postgraduate Medical Journal|April 1, 1985
Atrial myxoma presenting with cerebral haemorrhageV M Macaulay, P J Crawford, R O McKeran
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-cateninM P Playford, D Bicknell, W F Bodmer, et al.
The Journal of Endocrinology|September 1, 1993
Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymesV J Frost, V M Macaulay, J A Wass, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapyV M Macaulay, R H Begent, M E Phillips, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
[D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P inhibits the growth of human small cell lung cancer xenografts in vivoM J Everard, V M Macaulay, J L Millar, et al.
British Journal of Cancer|March 1, 1992
In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growthM J Everard, V M Macaulay, J L Miller, et al.
Pageof 3